SAN FRANCISCO, January 25, 2017 /PRNewswire/ --
The global sepsis diagnostics market is expected to reacha value of USD 874.6 million by 2025, according to a new report by Grand View Research, Inc. Rising prevalence of sepsis is the most significant factor anticipated to drive the market growth during the forecast period.
According to the National Center for Biotechnology Information, the number of patients suffering from septic poisoning rose by an average of 5.7% each year. As a result of this, there is a rising need for early diagnosis of such blood-poisoning diseases amongst patients. High prevalence of sepsis is also leading to a huge mortality rate, which is triggering early diagnosis to execute the clinical intervention.
Rising number of hospital-acquired infections are also expected to support the growth of the market over the forecast period. Hospital-acquired infections majorly include urinary tract & surgical site infections, which result into sepsis. According to WHO, 7 out of every 100 hospitalized patients develop hospital-acquired infections in developed countries. Thus, such infections significantly cause septicemia, which will resultantly raise the need for early diagnosis. On the other hand, pneumonia is also an important driving factor for high demand of sepsis diagnostics as it is one of the major causes for septic shock.
Browse full research report with TOC on "Sepsis Diagnostics Market Analysis By Product (Instruments, Blood Culture Media, Assay Kits), By Technology (Microbiology, Molecular Diagnostics, Immunoassays), By Testing Type (Laboratory, PoC), By Pathogen, And Segment Forecasts, 2014 - 2025 at: http://www.grandviewresearch.com/industry-analysis/sepsis-diagnostics-market
Further key findings from the study suggest:
Browse related reports by Grand View Research:
Grand View Research has segmented the sepsis diagnostics market on the basis of product, technology, pathogen, testing type, and region:
Read Our Blog - Sepsis diagnosis: An effective solution for reduction in sepsis mortality rate
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected]
SOURCE Grand View Research, Inc.
Subscribe to our Free Newsletters!
Opportunistic infections are microbial infections that can cause disease in persons with a weak ...
The state health insurance programs provide health care support to the below poverty line (BPL) ...
There is a lining between the lungs and chest wall known as Pleura. The dismissal of pleura by a ...View All